(RTTNews.com) - Amgen ( AMGN ) announced that Jonathan Peacock, executive vice president or EVP and chief financial officer or CFO, is leaving Amgen to pursue broader career opportunities. Michael Kelly, an 11-year Amgen veteran, has been named acting CFO.<br /><br />The company said Peacock will be stepping down from his role as CFO effective Friday, Jan. 10, 2014, and is expected to remain employed with the company until May to assist with the transition.<br /><br />In his role as acting CFO, Kelly will be responsible for the company's finance and investor relations operations, Amgen said.<br /><br />Since joining Amgen in 2003, he has served in a number of executive finance assignments, including five years as chief accounting officer and more recently as CFO for international commercial operations. Prior to joining Amgen, Kelly had finance roles at Tanox, Biogen and Monsanto Life Sciences.<br />